EP0970109A2 - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them

Info

Publication number
EP0970109A2
EP0970109A2 EP98911532A EP98911532A EP0970109A2 EP 0970109 A2 EP0970109 A2 EP 0970109A2 EP 98911532 A EP98911532 A EP 98911532A EP 98911532 A EP98911532 A EP 98911532A EP 0970109 A2 EP0970109 A2 EP 0970109A2
Authority
EP
European Patent Office
Prior art keywords
amino acid
seq
polynucleotide
protein
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98911532A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kenneth Jacobs
John M. Mccoy
Edward R. Lavallie
Lisa A. Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J. Agostino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of EP0970109A2 publication Critical patent/EP0970109A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
EP98911532A 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them Withdrawn EP0970109A2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81538197A 1997-03-11 1997-03-11
US815381 1997-03-11
US3632198A 1998-03-06 1998-03-06
US36321 1998-03-06
PCT/US1998/004601 WO1998040404A2 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Publications (1)

Publication Number Publication Date
EP0970109A2 true EP0970109A2 (en) 2000-01-12

Family

ID=26713058

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98911532A Withdrawn EP0970109A2 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP0970109A2 (ja)
JP (1) JP2001514520A (ja)
AU (1) AU6546898A (ja)
CA (1) CA2283193A1 (ja)
WO (1) WO1998040404A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2360585A1 (en) * 1999-01-22 2000-07-27 Memorec Medical Molecular Research Cologne Stoffel Gmbh Protease
AU5751000A (en) 1999-06-18 2001-01-09 Brook Biotechnologies, Inc. Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
AU2001243508A1 (en) 2000-03-08 2001-09-17 Complexe Hospitalier De La Sagamie Very low density lipoprotein receptor polymorphisms and uses therefor
US20020132244A1 (en) 2000-09-27 2002-09-19 Xiao-Cheng Li-Sucholeiki Methods for detecting rare polymorphic variants in genomic DNA sequences
WO2012068463A2 (en) 2010-11-18 2012-05-24 Beth Israel Deaconess Medicall Center, Inc. Methods of treating obesity by inhibiting nicotinamide n-methyl transferase (nnmt)
KR20210082212A (ko) * 2018-10-25 2021-07-02 아지노모토 가부시키가이샤 단백질의 분비 생산법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9840404A2 *

Also Published As

Publication number Publication date
WO1998040404A3 (en) 1998-12-30
JP2001514520A (ja) 2001-09-11
AU6546898A (en) 1998-09-29
WO1998040404A2 (en) 1998-09-17
CA2283193A1 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
CA2269755A1 (en) Secreted proteins and polynucleotides encoding them
WO1998049302A1 (en) Secreted proteins and polynucleotides encoding them
CA2283195A1 (en) Secreted proteins and polynucleotides encoding them
CA2274732A1 (en) Secreted proteins and polynucleotides encoding them
CA2306457A1 (en) Secreted proteins and polynucleotides encoding them
EP1007661A2 (en) Secreted proteins and polynucleotides encoding them
EP0971950A2 (en) Secreted proteins and polynucleotides encoding them
WO1997046682A2 (en) Polynucleotides from human adult pbmc encoding secreted proteins
EP0970109A2 (en) Secreted proteins and polynucleotides encoding them
EP0966530A2 (en) Secreted proteins and polynucleotides encoding them
WO1998031802A2 (en) Secreted proteins and polynucleotides encoding them
CA2281015A1 (en) Secreted proteins and polynucleotides encoding them
WO1998024905A2 (en) Secreted proteins and polynucleotides encoding them
WO1998020130A2 (en) Secreted proteins and polynucleotides encoding them
WO1998030582A2 (en) Secreted proteins and polynucleotides encoding them
EP1007660A2 (en) Secreted proteins and polynucleotides encoding them
EP0996722A2 (en) Secreted proteins and polynucleotides encoding them
WO1998053065A1 (en) Human semaphorin e and polynucleotides encoding it
WO1998036067A2 (en) Secreted proteins and polynucleotides encoding them
WO1998014576A2 (en) Secreted proteins and polynucleotides encoding them
WO1998056805A1 (en) Secreted proteins and polynucleotides encoding them
EP1003768A1 (en) Secreted proteins and polynucleotides encoding them
AU5159998A (en) Secreted proteins and polynucleotides encoding them
EP0915971A2 (en) Polynucleotides from human adult pbmc endocing secreted proteins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991011

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENETICS INSTITUTE, LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030127